The utility of monitoring carcinoembyronic antigen during systemic therapy for advanced colorectal cancer

Oncology Reports

Volumn 5, Issue 3, 1998, Pages 559-567

  Grem, Jean L ^a   Steinberg, Seth M ^a   Chen, Alice P ^a   McAtee, Manette ^a   Cullen, Ellen ^a   Michael Hamilton, J ^a   Allegra, Carmen J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Carcinoembryonic antigen; Colon cancer; Prognostic indicators; Rectal cancer; Tumor markers

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; RECOMBINANT ALPHA2A INTERFERON; SPARFOSIC ACID;

ADULT; ADVANCED CANCER; AGED; ANTIGEN DETECTION; ARTICLE; CANCER GROWTH; CLINICAL TRIAL; COLORECTAL CANCER; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031959151     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.3.559     Document Type: Article

References (28)

1. Fletcher RH: Carcinoembryonic antigen. Ann Int Med 104: 66-73, 1986.
2. Posner M and Mayer R: The use of serologic tumor markers in gastrointestinal malignancies. Hematol Oncol Clin N Amer 8: 533-553, 1994.
3. Cohen AM, Minsky BD and Schilsky RL: Colon cancer. In: Cancer: Principles and Practice of Oncology. 4th edition. DeVita CT Jr, Hellman S and Rosenberg SA (eds.) JB Lippincot Co., Philadelphia, pp929-977, 1993.
4. Steele G: Standard postoperative monitoring of patients after primary resection of colon and rectum cancer. Cancer 71: 4225-4235, 1993.
5. Bruinvels DJ, Stiggelbout AM, Kievit J, van Houwelingen HC, Habbema JDF and van de Velde CJH: Follow-up of colorectal cancer patients. A meta-analysis. Ann Surg 219: 174-182, 1994.
6. Ravry M, Moertel C, Schutt A and Go V: Usefulness of serial serum Carcinoembryonic antigen (CEA) determinations during anticancer therapy or long-term follow-up of gastrointestinal carcinoma. Cancer 34: 1230-1234, 1974.
7. Webb A, Scott-Mackie P, Cunningham D, Norman A, Andreyev J, O'Brien M and Bensten J: The prognostic value of CEA, βHCG, AFP, CA125, CA19-9 and c-erb B-2, βHCG immunohistochemistry in advanced colorectal cancer. Ann Oncol 6: 581-587, 1995.
8. Girard P, Ducreux M, Baldeyrou P, et al: Surgery for lung metastases from colorectal cancer: analysis of prognostic factors. J Clin Oncol 14: 2047-2053, 1996.
9. Morris DL and Ross WB: Australian experience of cryoablation of liver tumors. Surg Oncol Clin N Amer 5: 391-397, 1996.
10. Fountzilas G, Gossios K, Zisiadis A, Svarna E, Skarlos D and Pavlidis N: Prognostic variables in patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy. Med Pediat Oncol 26: 305-317, 1996.
11. Skarin A, Delwiche R, Zamcheck N, Lockich J and Frei E: Carcinoembryonic antigen: Clinical correlation with chemotherapy for metastatic gastrointestinal cancer. Cancer 33: 1239-1245, 1974.
12. Young V, Kashmiri R, Hazen Z and Meeker W: Usefulness of serial Carcinoembryonic antigen (CEA) determinations in monitoring chemotherapy. Southern Med J 69: 1274-1276, 1976.
13. Mayer R, Garnick M, Steele G and Zamcheck N: Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancer. Cancer 42: 1428-1433, 1978.
14. Ichiki A, Krauss S, Israelsen K, Sonoda T and Collmann I: Sequential carcmoembryonic antigen levels: A predictor of response and relapse in combination chemotherapy of advanced gastrointestinal cancer. Oncology 38: 27-30, 1981.
15. Staab HJ, Anderer FA, Hornung A, Stumpf E and Fisher R: Doubling time of circulating CEA and its relation to survival of patients with recurrent colorectal cancer. Br J Cancer 46: 773-781, 1982.
16. Carl J, Brunsgaard N, Kjaer M and Norgaard-Pedersen B: Estimated treatment responses in metastatic colorectal carcinoma based on longitudinal carcinoembryonic antigen series. Scand J Clin Lab Invest 53: 829-834, 1993.
17. Leichman CG, Leichman L, Spears CP, Rosen PJ, Jeffers S and Groshen S: Prolonged continuous infusion of fluorouracil with weekly bolus leucovorin: a phase II study in patients with disseminated colorectal cancer. J Natl Cancer Inst 85: 41-44, 1993.
18. Ward U, Primrose J, Finan P, Perren T, Selby P, Purves D, et al. The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer. Br J Cancer 67: 1132-1135, 1993.
19. Grem J, McAtee N, Murphy RF, et al: A pilot study of interferon alpha-2a in combination with fluorouracil plus highdose leucovorin in metastatic gastrointestinal carcinoma. J Clin Oncol 9: 1811-1820, 1991.
20. Grem J, McAtee N, Murphy R, et al: Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarinoma. J Clin Oncol 12: 560-568, 1994.
21. Grem J, McAtee N, Steinberg S, Hamilton J, Murphy R, Drake J, et al: A phase I study of continuous infusion 5-fluorouracil plus calcium teucovorin in combination with N-(phosphonacetyl)-l-aspartate in metastatic gastrointestinal adenocarcinoma. Cancer Res 53: 4828-4836, 1993.
22. Grem J, Jordan E, Robson M, et al: Phase II study of fluorouracil, leucovorin and interferon alpha-2a in metastatic colorectal carcinoma. J Clin Oncol 11: 1737-1745, 1993.
23. Grem J, McAtee N, Murphy R, et al: A phase I study of interferon gamma-lb in combination with fluorouracil, leucovorin and interferon alpha-2a. Clin Cancer Res 3: 1125-1134, 1997.
24. Oken MM, Creech RH, Tormey DC, et al: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649-655, 1982.
25. Kaplan E and Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
26. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1966.
27. Cox D: Regression models and lifetables. J R Stat Soc (B) 34: 187-202, 1972.
28. Matthews DE and Farewell VT: Using and Understanding Medical Statistics. Karger, Basel, pp148-158, 1985.